Article
Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2017
Hu Yuebi, Alden Ryan S, Odegaard Justin I, Fairclough Stephen R, Chen Ruthia, Heng Jennifer, Feeney Nora, Nagy Rebecca J, Shah Jayshree, Ulrich Bryan, Gutierrez Martin, Lanman Richard B, Garber Judy E, Paweletz Cloud P, Oxnard Geoffrey R
Abstract excerpt
Purpose: Plasma cell-free DNA (cfDNA) analysis is increasingly used clinically for cancer genotyping, but may lead to incidental identification of germline-risk alleles. We studied EGFR T790M mutations in non-small cell lung cancer (NSCLC) toward the aim of discriminating germline and cancer-derived variants within cfDNA.Experimental Design: Patients with EGFR-mutant NSCLC, some with known germline EGFR T790M,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
